John Schoellerman
Chief Investment Officer bei OXFORD NANOPORE TECHNOLOGIES PLC
Profil
John Schoellerman is currently the Chairman at Eagle Genomics Ltd.
and the SVP-Corporate Development & Investment at Oxford Nanopore Technologies Plc.
He was previously the Managing Director & Head-Medtech at Lazard Services Holdings Ltd.
He completed his undergraduate degree at Harvard University and earned an MBA from INSEAD.
Aktive Positionen von John Schoellerman
| Unternehmen | Position | Beginn |
|---|---|---|
| OXFORD NANOPORE TECHNOLOGIES PLC | Chief Investment Officer | 01.01.2019 |
Eagle Genomics Ltd.
 Eagle Genomics Ltd. Packaged SoftwareTechnology Services Eagle Genomics Ltd. provides bioinformatics software and services. The firm products include eaglecore and eaglensembl. Its services include NGS data management, analysis, and visualization, and cloud computing for bioinformatics, biomarker discovery, microarray analysis, reproducing methods, and custom software development. The company was founded by Abel Ureta-Vidal in 2008 and is headquartered in Cambridge, the United Kingdom. | Chairman | 29.09.2023 |
Ehemalige bekannte Positionen von John Schoellerman
| Unternehmen | Position | Ende |
|---|---|---|
| Lazard Services Holdings Ltd. | Corporate Officer/Principal | - |
Ausbildung von John Schoellerman
| Harvard University | Undergraduate Degree |
| INSEAD | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| OXFORD NANOPORE TECHNOLOGIES PLC | Electronic Technology |
| Private Unternehmen | 2 |
|---|---|
| Lazard Services Holdings Ltd. | |
Eagle Genomics Ltd.
Eagle Genomics Ltd. Packaged SoftwareTechnology Services Eagle Genomics Ltd. provides bioinformatics software and services. The firm products include eaglecore and eaglensembl. Its services include NGS data management, analysis, and visualization, and cloud computing for bioinformatics, biomarker discovery, microarray analysis, reproducing methods, and custom software development. The company was founded by Abel Ureta-Vidal in 2008 and is headquartered in Cambridge, the United Kingdom. | Technology Services |
